clinical-trials

Documents about clinical-trials

• Identifying research particiaption effects through qualitative methods: Feedback from Research Engagement Consultants involved in a pediatric mental health comparative effectiveness trial#20023DOAJ
• The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM#121829HAL (France)
• The erosion of proof in paradigm transitions: the rise of narrative rationality in health technology assessment#669964HAL (France)
• Long-Term Safety Follow-Up Study of SCM-AGH in Subjects Who Participated and Administered SCM-AGH in to Severe Atopic Dermatitis Clinical Trials#826596ClinicalTrials.gov
• Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials#826674ClinicalTrials.gov
• Quad Helix vs RME for Posterior Cross-bite in Egyptian Children#827851ClinicalTrials.gov
• Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking#837456ClinicalTrials.gov
• Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease#889973ClinicalTrials.gov
• TASK-002: Bioequivalence of Bedaquiline 400mg Administered in Crushed Form Compared to Tablet Form in Healthy Male and Female Adults Under Fed Conditions (BDQ Crush Study)#912273ClinicalTrials.gov
• Reviving Purpose Limitation and Data Minimisation in Personalisation, Profiling and Decision-Making Systems#964619OpenAlex
• Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer#982519ClinicalTrials.gov
• Memory-Based Strategies for Antiretroviral Medication Management: An Evaluation of Clinical Predictors, Adherence Behavior Awareness, and Effectiveness#675839eScholarship
• <i>In vivo</i> models for evaluating antibacterial activity and osseointegration of dual-biofunctional implant coatings: A systematic review#4611Europe PMC
• Determining the optimal irrigation activation or agitation techniques for postoperative pain control: A network meta-regression of clinical trials#4756Europe PMC
• Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer#805135ClinicalTrials.gov
• Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer#828606ClinicalTrials.gov
• Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer#830215ClinicalTrials.gov
• Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer#832652ClinicalTrials.gov
• Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations#871859ClinicalTrials.gov
• Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance#979776ClinicalTrials.gov
• Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma#642068eScholarship
• mRNA vaccines and therapeutics beyond COVID-19: A review of the global clinical development landscape, low- and middle-income countries involvement and relevance to their contexts#4586Europe PMC
• Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1–Infected Women#642151eScholarship
• A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression#311115ClinicalTrials.gov
• Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease#329471ClinicalTrials.gov
• Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners#374400HAL (France)
• Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery#898768ClinicalTrials.gov
• Optimizing Outcomes of Treatment-Resistant Depression in Older Adults#1009466ClinicalTrials.gov
• Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery#1032284ClinicalTrials.gov
• Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial#262149HAL (France)
• Short Communication: Higher Tenofovir Concentrations in Hair Are Associated with Decreases in Viral Load and Not Self-Reported Adherence in HIV-Infected Adolescents with Second-Line Virological Treatment Failure#619890eScholarship
• Individualized Texting for Adherence Building (iTAB): Improving Antiretroviral Dose Timing Among HIV-Infected Persons with Co-occurring Bipolar Disorder#675831eScholarship
• Comparative effectiveness of different inhaler technique education modalities on clinical outcomes in patients with asthma and chronic obstructive pulmonary disease: a protocol for a systematic review and network meta-analysis of randomised controlled trials.#309019NCBI PubMed Central
• Severity bands for atopic dermatitis measures: analysis from adult dupilumab randomized clinical trials / Andreas Wollenberg, Eric L. Simpson, Yael A. Leshem, Alain Taïeb, Norito Katoh, Jingdong Chao, Ana B. Rossi, Amy H. Praestgaard#783932Deutsche Nationalbibliothek
• Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation#833077ClinicalTrials.gov
• Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)#897760ClinicalTrials.gov
• Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial#966178ClinicalTrials.gov
• Reporting individual results for biomonitoring and environmental exposures: lessons learned from environmental communication case studies#612143eScholarship
• Impact of indispensable amino acid supplementation on gut function in children at high risk of environmental enteropathy: protocol for an international coordinated group of randomised controlled trials#374360HAL (France)
• Assessing the impact of manual therapy in the management of nonspecific low back pain: a scoping review of the outcomes used in clinical trials#395399HAL (France)
• Learning to Limit Data Collection via Scaling Laws: A Computational Interpretation for the Legal Principle of Data Minimization#679061OpenAlex
• Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers#802054ClinicalTrials.gov
• Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: Early Test-of-cure#917367ClinicalTrials.gov
• A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group#143666ClinicalTrials.gov
• PROState Pathway Embedded Comparative Trial#805879ClinicalTrials.gov
• Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer#807224ClinicalTrials.gov
• Effects of Cognitive Training on Chemotherapy-Induced Cognitive Impairment in Colon Cancer Patients Undergoing Treatment(Chemobrain) in Oncology Patients With Colon Cancer Undergoing Active Treatment#839350ClinicalTrials.gov
• Network Meta-analyses of Artificially Sweetened Beverages and Cardiometabolic Risk#839632ClinicalTrials.gov
• Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer#849358ClinicalTrials.gov
• JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and Safety#887412ClinicalTrials.gov